Gujarat Themis Biosyn is at narrow range patternConsolidation with inner triangle
pattern in very narrow range
4.83 INR
591.63 M INR
1.70 B INR
30.81 M
About GUJARAT THEMIS BIOSYN LTD
Sector
CEO
Tapas B. Guhathakurata
Headquarters
Mumbai
Website
Founded
1981
ISIN
INE942C01045
FIGI
BBG000CS5S61
Gujarat Themis Biosyn Ltd. operates as a pharmaceutical company. The firm engages in the manufacture of drugs. Its products include Rifamycin and Lovastatin. The company was founded on December 11, 1981 and is headquartered in Mumbai, India.
Breakout Stock with strong fundamentalStock Name : - Gujrat Themis Biosyn Ltd.
Stock has given a breakout on weekly Time frame.
Strong Uptrend Seen ON Chart.
Company has delivered good profit growth of 71.8% CAGR over last 5 years.
Debt to Equity Ratio - 0.00
buy above 285, target openIf one is going to invest in pharma then y not consider a stock which is having good fundamental along with highest ROE(77%) in the sector. iolcp comes 2nd (56%)
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange GUJARAT THEMIS BIOSYN LTD stocks are traded under the ticker GUJTHEM.
GUJTHEM stock has fallen by −9.78% compared to the previous week, the month change is a −9.78% fall, over the last year GUJARAT THEMIS BIOSYN LTD has showed a −9.78% decrease.
GUJTHEM stock is 12.37% volatile and has beta coefficient of 1.45. Track GUJARAT THEMIS BIOSYN LTD stock price on the chart and check out the list of the most volatile stocks — is GUJARAT THEMIS BIOSYN LTD there?
Yes, you can track GUJARAT THEMIS BIOSYN LTD financials in yearly and quarterly reports right on TradingView.
GUJTHEM net income for the last quarter is 129.72 M INR, while the quarter before that showed 105.66 M INR of net income which accounts for 22.77% change. Track more GUJARAT THEMIS BIOSYN LTD financial stats to get the full picture.
GUJARAT THEMIS BIOSYN LTD dividend yield was 0.25% in 2023, and payout ratio reached 12.28%. The year before the numbers were 0.79% and 67.67% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 26, 2025, the company has 265.00 employees. See our rating of the largest employees — is GUJARAT THEMIS BIOSYN LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GUJARAT THEMIS BIOSYN LTD EBITDA is 737.36 M INR, and current EBITDA margin is 46.38%. See more stats in GUJARAT THEMIS BIOSYN LTD financial statements.
Like other stocks, GUJTHEM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GUJARAT THEMIS BIOSYN LTD stock right from TradingView charts — choose your broker and connect to your account.